Showing results (441-450 of 584) with videos related to
Sort By:
Pageof 59
Journal of the National Cancer Institute|March 1, 1982
Growth and spontaneous regression of swine melanoma: relationship of in vitro leukocyte reactivityJ Berkelhammer, B M Ensign, R R Hook, et al.Lancet (London, England)|November 9, 2000
AIDS across Europe, 1994-98: the EuroSIDA studyA Mocroft, C Katlama, A M Johnson, et al.JAMA|April 13, 1994
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study GroupJ D Lundgren, A N Phillips, C Pedersen, et al.AIDS (London, England)|November 4, 2000
The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral loadV Miller, C A Sabin, A N Phillips, et al.AIDS (London, England)|May 1, 1993
Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineagesG Janossy, N Borthwick, R Lomnitzer, et al.Lancet (London, England)|July 11, 2003
Decline in the AIDS and death rates in the EuroSIDA study: an observational studyA Mocroft, B Ledergerber, C Katlama, et al.Clinical and Experimental Immunology|May 1, 1992
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosisM Bofill, G Janossy, C A Lee, et al.AIDS Research and Human Retroviruses|October 13, 2005
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfectionA Mocroft, A N Phillips, V Soriano, et al.HIV Medicine|March 14, 2007
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or deathC Holkmann Olsen, A Mocroft, O Kirk, et al.Epidemiology and Infection|February 1, 2003
Regional and temporal changes in AIDS in Europe before HAARTA Blaxhult, Z Fox, R Colebunders, et al.Pageof 59